Expression of immunohistochemical markers according to histological type in patients with early gastric cancer

Scand J Gastroenterol. 2016 Jan;51(1):60-6. doi: 10.3109/00365521.2015.1065510. Epub 2015 Jul 4.

Abstract

Objective: We compared the biological characteristics of early gastric cancer (EGC) using immunohistochemical (IHC) staining among histological types.

Materials and methods: IHC staining results were analyzed in 86 EGCs resected with endoscopic submucosal dissection to identify mucin phenotype and biological characteristics.

Results: The histological type was classified as tubular adenocarcinoma (TAC), mixed adenocarcinoma (MAC), or poorly cohesive carcinoma (PCC). Significant differences in MUC-2 (34.4% vs. 10.7%, p < 0.05) and MUC-5AC (59.4% vs. 85.7%, p < 0.05) expression were observed between TAC and PCC. The poorly cohesive component of MAC showed stronger immunoreactivity to CD10 (46.2% vs. 14.3%, p < 0.05) but weaker reactivity to MUC-5AC (57.7% vs. 85.7%, p < 0.05), compared to that of PCC. E-cadherin and β-catenin expression levels significantly decreased in the poorly cohesive component of MAC (15.4% vs. 90.6%, p < 0.05; 7.7% vs. 90.6%, p < 0.05, respectively) and PCC (10.7% vs. 90.6%, p < 0.05; 14.3% vs. 90.6%, p < 0.05, respectively), compared to TAC. However, vascular endothelial growth factor expression significantly increased in the poorly cohesive component of MAC (42.3% vs. 9.4%, p < 0.05) and PCC (39.3% vs. 9.4%, p < 0.05), compared to TAC.

Conclusion: IHC analysis showed that EGC histological types differ in terms of mucin phenotype and biological characteristics. The poorly cohesive components showed decreased E-cadherin and β-catenin expression levels and increased vascular endothelial growth factor expression. These characteristics may contribute to the poor prognosis of patients with MAC and PCC.

Keywords: early gastric cancer; endoscopic submucosal dissection; histological type; immunohistochemistry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology*
  • Adult
  • Aged
  • Antigens, CD
  • Biomarkers, Tumor / metabolism*
  • Cadherins / metabolism
  • Endoscopy
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Mucin 5AC / metabolism
  • Mucin-2 / metabolism
  • Prognosis
  • Republic of Korea
  • Stomach Neoplasms / pathology*
  • Tertiary Care Centers
  • Vascular Endothelial Growth Factor A / metabolism
  • beta Catenin / metabolism

Substances

  • Antigens, CD
  • Biomarkers, Tumor
  • CDH1 protein, human
  • CTNNB1 protein, human
  • Cadherins
  • MUC2 protein, human
  • MUC5AC protein, human
  • Mucin 5AC
  • Mucin-2
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • beta Catenin